First test of new liver drug in healthy people
NCT ID NCT07110441
Summary
This was an early-stage study to see how the body processes a potential new drug called G1090N and to check if it is safe for people. It involved 52 healthy volunteers who received the drug. The main goal was to measure how long the drug stays in the body and to watch for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ON CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anaheim Clinical Trials, LLC
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.